PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological?

Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological?
2023-08-21
(Press-News.org)

“Our findings may provide a useful therapeutic approach for treating breast cancer patients who may suffer from early relapse and intrinsic resistance.” 

BUFFALO, NY- August 16, 2023 – A new editorial paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, “Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?”

A vast majority of breast cancers (~70%) are estrogen receptor-alpha positive (ER+), for which endocrine therapy is the common treatment. However, recurrence often occurs leading to tumor progression, metastasis and eventually patient death, and the underlying molecular mechanisms remain poorly understood. In this new editorial, researchers Chia-Chia Liu and Xiao-Song Wang from the University of Pittsburgh discuss their recent study regarding recurrent gene fusions — hallmarks of some cancers that resulted either from chromosomal rearrangements or from cis- or trans-splicing. 

“Importantly, selected oncogenic fusions have been matched with effective targeted therapy in several solid tumors. For instance, EML4-ALK, one of the most important oncogenic driver genes of non-small cell lung cancer (NSCLC) uncovered in recent years.”

In addition to gene fusions resulting from genomic rearrangements, a read-through SLC45A3-ELK4 fusion transcript has been identified in prostate cancer which is associated with disease progression and metastasis. Although the whole genome and RNA sequencing provide an effective way to detect fusion genes, the downstream identification and validation of fusion genes or their products in solid tumors remains a major challenge. Through analysis of RNA-seq data from TCGA, the authors of this editorial and their co-authors recently identified a neoplastic fusion transcript RAD51AP1-DYRK4 in luminal B breast cancer (~17.5%) showing higher ki67 expression which is an indication of aggressive clinical characteristics.

“In this study, we examined the utility of MEK inhibitor trametinib (Mekinist) currently used for treating melanoma with BRAF mutations, in blocking the MEK-ERK signaling driven by RAD51AP1-DYRK4 fusion. Interestingly [...] RAD51AP1-DYRK4 may endow sensitivity to MEK inhibition in luminal B breast cancer [13]. To our knowledge, this is one of the few non-traditional fusions generated by read-through events in the absence of DNA rearrangement that play an important role in tumorigenesis.”

 

Read the full editorial: DOI: https://doi.org/10.18632/oncotarget.28438 

Correspondence to:  Xiao-Song Wang

Email: xiaosongw@pitt.edu 

Keywords: luminal B breast cancer, RAD51AP1-DYRK4, MEK inhibitor, chimerical transcript
 

About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

Twitter  Facebook  YouTube  Instagram  LinkedIn  Pinterest  LabTube Soundcloud  

Sign up for free Altmetric alerts about this article: https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28438 

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact: media@impactjournals.com.

 

Oncotarget Journal Office

6666 East Quaker Str., Suite 1A

Orchard Park, NY 14127

Phone: 1-800-922-0957 (option 2)

###

END


[Attachments] See images for this press release:
Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological? Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological? 2

ELSE PRESS RELEASES FROM THIS DATE:

Eye scans detect signs of Parkinson’s disease up to seven years before diagnosis

2023-08-21
Markers that indicate the presence of Parkinson’s disease in patients on average seven years before clinical presentation have been identified by a UCL and Moorfields Eye Hospital research team. This is the first time anyone has shown these findings several years before diagnosis, and these results were made possible by the largest study to date on retinal imaging in Parkinson’s disease. The study, published today in Neurology®, the medical journal of the American Academy of Neurology, identified markers of Parkinson’s in eye scans with the help of artificial ...

Did sabertooth tigers purr or roar?

Did sabertooth tigers purr or roar?
2023-08-21
When a sabertooth tiger called out, what noise did it make – a mighty roar or a throaty purr? A new study from North Carolina State University examined the data behind the arguments for each vocalization and found that the answer was more nuanced than they thought – and that it could depend on the shape of a few small bones. Modern cats belong to one of two groups: either the pantherine “big cats,” including the roaring lions, tigers and jaguars; or Felinae “little cats,” which include purring ...

Thinning ice sheets may drive sharp rise in subglacial waters

Thinning ice sheets may drive sharp rise in subglacial waters
2023-08-21
Two Georgia Tech researchers, Alex Robel and Shi Joyce Sim, have collaborated on a new model for how water moves under glaciers. The new theory shows that up to twice the amount of subglacial water that was originally predicted might be draining into the ocean – potentially increasing glacial melt, sea level rise, and biological disturbances. The paper, published in Science Advances, “Contemporary Ice Sheet Thinning Drives Subglacial Groundwater Exfiltration with Potential Feedbacks on Glacier Flow”, is co-authored by Colin Meyer (Dartmouth), Matthew Siegfried (Colorado School of Mines), and Chloe Gustafson (USGS). While there are pre-existing methods to understand ...

New research finds way to reduce bias in children

2023-08-21
Children’s views of inequality may be influenced by how its causes are explained to them, finds a new study by a team of psychology researchers. The work offers insights into the factors that affect how larger social issues are perceived at a young age and points to new ways to reduce bias toward lower-status economic groups. “When making sense of social inequalities, adults may consider the structural forces at play—for example, people may cite policies related to legacy admissions when thinking about how disparities first arise,” says Rachel Leshin, a New York University doctoral student and the lead ...

It all depends on the genetic diversity

It all depends on the genetic diversity
2023-08-21
Plants are not exposed to herbivores without defenses. When an insect feeds on a leaf, thereby wounding it and releasing oral secretions, a signaling cascade is elicited in the plant, usually starting with a rapid increase in the amount of the plant hormone jasmonic acid and its active isoleucine conjugate. Jasmonic acid regulates various reactions in plants, including defenses against herbivores and responses to environmental stress. Mutants with disadvantageous properties do not necessarily disappear An important thesis of evolutionary theory is natural selection and the conclusion that mutants with disadvantageous properties disappear ...

UArizona Valley fever expert Galgiani to receive lifetime achievement award

UArizona Valley fever expert Galgiani to receive lifetime achievement award
2023-08-21
The Arizona Bioindustry Association announced that renowned Valley fever researcher John Galgiani, MD, professor and director of the Valley Fever Center for Excellence at the University of Arizona College of Medicine – Tucson, is the 2023 recipient of the AZBio Pioneer Award for Lifetime Achievement. The Pioneer Award is the highest honor awarded by Arizona’s bioscience community and is extended to an Arizonan whose body of work has made life better for people at home and around the world. Galgiani’s four decades of Valley fever research, ...

University breaks ground on one-of-a-kind semiconductor facility

University breaks ground on one-of-a-kind semiconductor facility
2023-08-21
The University of Arkansas celebrated an important milestone with the groundbreaking on a building that Chancellor Charles Robinson suggested might someday rival the U of A’s most iconic structure, Old Main, in significance to the university and the state of Arkansas. Robinson and other university leaders, including University of Arkansas System President Don Bobbitt and members of the U of A System Board of Trustees, as well as researchers and industry leaders, gathered at the Arkansas Research and Technology Park in South Fayetteville to celebrate construction of the national Multi-User Silicon Carbide ...

Do prisons hold the key to solving the opioid crisis?

2023-08-21
With opioid overdose deaths surging in the United States, many communities are in desperate need of solutions to bring down the body count. Among the most promising is strengthening prison reentry programs for highest-risk users, a Rutgers-led study has found.   “For people who use drugs and have been in prison for several years, the reentry period can be chaotic and disorienting,” said Grant Victor, an assistant professor in the Rutgers School of Social Work and lead author of the study published in the Journal of Offender Rehabilitation.   “Closing ...

AI to predict critical care for patients with COVID-19

AI to predict critical care for patients with COVID-19
2023-08-21
The COVID-19 pandemic dealt a huge blow to healthcare systems and highlighted their major shortcomings. As of June 2023, there have been over 760 million confirmed cases of COVID-19, with almost 7 million deaths worldwide. During the major COVID-19 outbreaks, hospitals often had their intensive care units (ICU) running at full capacity for providing invasive mechanical ventilation to patients who were diagnosed as positive for COVID-19. These ICUs often operated with insufficient staff and intubation equipment. One way to mitigate such problems is to accurately predict the prognosis ...

Simple blood test may predict future heart, kidney risk for people with Type 2 diabetes

2023-08-21
Research Highlights: An analysis of a clinical trial of more than 2,500 people with Type 2 diabetes and kidney disease found that high levels of four biomarkers are strongly predictive for the development of heart and kidney issues. People who took canagliflozin, a sodium glucose co-transporter 2 inhibitor (SGLT2 inhibitor), had lower levels of the four biomarkers compared to those who took a placebo over the three-year study period. Treatment with canagliflozin helped to substantially reduce the risk of hospitalization for heart failure and other heart complications among patients considered to have the highest risk. Embargoed until 1 p.m. CT/2 p.m. ET Monday, ...

LAST 30 PRESS RELEASES:

Study: How can low-dose ketamine, a ‘lifesaving’ drug for major depression, alleviate symptoms within hours? UB research reveals how

New nasal vaccine shows promise in curbing whooping cough spread

Smarter blood tests from MSU researchers deliver faster diagnoses, improved outcomes

Q&A: A new medical AI model can help spot systemic disease by looking at a range of image types

For low-risk pregnancies, planned home births just as safe as birth center births, study shows

Leaner large language models could enable efficient local use on phones and laptops

‘Map of Life’ team wins $2 million prize for innovative rainforest tracking

Rise in pancreatic cancer cases among young adults may be overdiagnosis

New study: Short-lived soda tax reinforces alternative presumptions on tax impacts on consumer behaviors

Fewer than 1 in 5 know the 988 suicide lifeline

Semaglutide eligibility across all current indications for US adults

Can podcasts create healthier habits?

Zerlasiran—A small-interfering RNA targeting lipoprotein(a)

Anti-obesity drugs, lifestyle interventions show cardiovascular benefits beyond weight loss

Oral muvalaplin for lowering of lipoprotein(a)

Revealing the hidden costs of what we eat

New therapies at Kennedy Krieger offer effective treatment for managing Tourette syndrome

American soil losing more nutrients for crops due to heavier rainstorms, study shows

With new imaging approach, ADA Forsyth scientists closely analyze microbial adhesive interactions

Global antibiotic consumption has increased by more than 21 percent since 2016

New study shows how social bonds help tool-using monkeys learn new skills

Modeling and analysis reveals technological, environmental challenges to increasing water recovery from desalination

Navy’s Airborne Scientific Development Squadron welcomes new commander

TāStation®'s analytical power used to resolve a central question about sweet taste perception

NASA awards SwRI $60 million contract to develop next-generation coronagraphs

Reducing antimicrobial resistance: accelerated efforts are needed to meet the EU targets

Gaming for the good!

Early adoption of sodium-glucose cotransporter-2 inhibitor in patients hospitalized with heart failure with mildly reduced or preserved ejection fraction

New study finds atrial fibrillation common in newly diagnosed heart failure patients, and makes prognosis significantly worse

Chitnis receives funding for study of wearable ultrasound systems

[Press-News.org] Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological?